why choose us

First received: September 08, 2023

Clinical Trial: Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Malignant Pleural Mesothelioma

Study Type: INTERVENTIONAL


Official Title: Breathprinting (E-Nose) Technology to Measure Response to Treatment of Malignant Pleural Mesothelioma (MPM) Through MPM-Specific Volatile Organic Compounds Detected in Exhalates

Brief Summary: The researchers are doing this study to test the ability of a new technology called breathprinting, or electronic nose (E-Nose), to measure how people respond to standard treatment for malignant pleural mesothelioma (MPM).The researchers will study how E-Nose breathprints change over time as people receive standard treatment for MPM.They will also look at how changes in people's E-Nose breathprints compare to changes in their standard imaging scans and in biomarkers of MPM in their blood.

Read more